GlassScriptPhysician profile
Cara L Riley
NPI 1578536017
$6,219.52
in general payments reported to CMS, 2019-2025
36 companies · $711 in 2025
The $711 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,236 · 2020: $246 · 2021: $761 · 2022: $903 · 2023: $1,218 · 2024: $1,144 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,073.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $565.99 | 2019-2025 | Evenity, Repatha, Otezla |
| Glaxosmithkline, LLC. | $540.63 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $505.09 | 2019-2025 | |
| Novo Nordisk INC | $504.25 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $502.74 | 2021-2024 | Freestyle Libre |
| Abbvie INC. | $427.14 | 2021-2025 | Qulipta, Ubrelvy |
| Lilly USA, LLC | $419.54 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Astellas Pharma US INC | $328.49 | 2019-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $325.91 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $249.27 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $236.57 | 2020-2024 | Xarelto |
| Allergan, INC. | $162.80 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $158.24 | 2019-2024 | Trulance, Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $157.12 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.76 | 2019-2023 | Jardiance |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.